id	submitter_id	entity_type	entity_id	category	classification	created_datetime	status	notes
4dae0ab9-74c3-58e6-a4f8-f77ab52bcf65	11933	case	e7d728e5-1a9f-4f27-9604-272e1235e08a	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.  Current TCGA tissue is reported as treated tissue.
c3b0f6f3-6575-583f-b9b2-aa24f9e9e4ea	679	case	d0de6676-6ba1-4d79-a9b0-ec3f1e8a8775	Qualified in error	Notification	2010-09-02T00:00:00	Approved	[intgen.org]: Qualified in Error - Decommissioned
bc78bd01-4e27-5f74-a72d-e90f7a5dd6eb	29661	case	737b35e1-d668-4fce-9b6e-76946c7952b6	Item may not meet study protocol	Observation	2015-10-09T00:00:00	Approved	Pt treated with dexmethasone and phenytoin sodium 6 days prior to procurement. According to the NIH, dexmethasone is an ancillary or hormone drug; SEER lists phenytoin sodium as an anticonvulsant to treat seizures.
a3699324-bf10-5166-a4bc-6f5fec3757d7	11654	case	b72fab50-aed2-48e7-b6ad-2a5bc7157cfd	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
cb6e1a1b-a932-573e-9a96-6a36be3cf742	3176	case	da5f6940-e8ee-4fd1-a8da-4cd68e02e59c	Neoadjuvant therapy	Notification	2011-07-27T00:00:00	Approved	Subject positive for neoadjuvant therapy.
fddb98f4-f268-572f-bfbc-023f34dc446f	829	case	e57b296a-80e9-4446-a3d1-3dbfeaf04f5e	Item may not meet study protocol	Observation	2010-10-28T00:00:00	Approved	Case identified (by Duke) as a secondary GBM; original annotation 06/22/09
759c302d-b112-54c9-b3e2-79a2015a75b3	11669	case	aa703529-7153-4f74-8577-2601876e3374	Normal tissue origin incorrect	Notification	2012-10-31T00:00:00	Approved	Samples were created as tssDNA from Normal Tissue.  Actually are tssDNA extracted from Blood.  Should have been 10A instead of 11A.
ba0126d7-458f-54ab-a521-929ade55a0ce	11670	case	e7d728e5-1a9f-4f27-9604-272e1235e08a	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
d30a0199-0aca-57c9-bc4a-0b2ce9ce7613	11651	case	de0cb811-bae0-407e-b8b3-97d1512bfa80	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
0e4a573b-161d-5af2-b048-1d9f4869a08c	11649	case	0553e60e-3510-417d-af8a-75947ebe8ab6	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
cefde9c8-918f-54bc-abcb-59798acd3ba5	11660	case	e117fe84-f003-40a4-96b5-8e26d0513151	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
c2f384da-f5a7-5116-8b65-194a960a20b4	11915	case	0ce23e2c-8e64-4391-8148-de823bce0d5f	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
a74160a6-4bf8-53b9-a5cc-7314ebf19f53	11926	case	f2de4316-026c-4c2d-b091-47bc0ec8612a	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
2072483e-e143-53d3-b5fb-8a552bd8c655	3178	case	06c427a1-8c2d-4003-b744-139114a04440	Neoadjuvant therapy	Notification	2011-07-27T00:00:00	Approved	Subject positive for neoadjuvant therapy.
40db17f0-c2c3-509f-b11f-35cb461bd709	23677	case	7a4c0a14-ac97-4c2b-a9cc-68cb561b2494	History of unacceptable prior treatment related to a prior/other malignancy	Notification	2014-11-18T00:00:00	Approved	Patient had prior breast malignancy with systemic radiation
7bad23a4-ad04-59aa-8dee-081d4ec5ffd2	11655	case	dfaae397-52c3-4d29-b665-971969e23432	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
82c4e0e4-aca5-5794-9bbd-0e5e98f75fdb	11913	case	5613f5f6-086d-470b-8f77-6dcb7f8625b7	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
84f3e5d4-5335-52fe-8326-7291a13705e5	11652	case	7ee03602-bfec-413d-a05b-609cf60c6481	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
30e86097-e380-5031-9be1-a17b1c120247	11919	case	cd73f38a-f6ff-4e7b-bd43-ec7b82dbe7df	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
2f2c33ff-60dd-560e-b4df-d2cf3ac7d562	830	case	025a7401-a65d-4ea0-8b4e-0ba775b0322a	Item may not meet study protocol	Observation	2010-10-28T00:00:00	Approved	Case identified (by Duke) as a secondary GBM; original annotation 06/22/09
80a3031f-bc11-5520-a112-33751f0d0b40	11648	case	d85fa9be-f7fb-407b-af46-31f495b210d6	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
c5a00bd8-56d6-5d9c-ba95-c263e689e162	618	case	a795a841-9fd6-4eac-b871-a8c70248700f	Molecular analysis outside specification	Notification	2010-09-02T00:00:00	Approved	[intgen.org]: Molecular Results off Spec
5724637b-52f6-5b50-a2d9-3cf1286a213c	1081	case	0d5e5a6b-5113-43f2-836c-776207b21b56	Subject withdrew consent	Redaction	2010-12-19T00:00:00	Approved	[intgen.org]: Subject Withdrew Consent
2a20a846-d356-5a6e-ab02-b6fc73f6d8d6	621	case	872511fb-98cd-4fba-82f6-4c3689c75ae2	Molecular analysis outside specification	Notification	2010-09-15T00:00:00	Approved	[intgen.org]: Molecular Results off Spec
68257502-9c06-5cd6-9cd6-92f0effa9596	11647	case	45a58ede-e7a4-424d-851e-e6a4062e46e4	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
058a03b7-3599-5b25-8a8f-f538efceebfb	830	case	025a7401-a65d-4ea0-8b4e-0ba775b0322a	Item may not meet study protocol	Observation	2010-10-28T00:00:00	Approved	Case identified (by Duke) as a secondary GBM; original annotation 06/22/14
bef0cb94-ca90-5b58-98d3-9bf97aa8df6b	11927	case	13b4d676-ee9b-499b-94bb-2365830fb37e	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
15a4e0ef-f926-54db-ad0a-b909b1c1e934	29662	case	6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02	Item may not meet study protocol	Observation	2015-10-09T00:00:00	Approved	Pt treated with oxcarbazepine 11 days prior to procurement. According to the NIH, this drug is an anticonvulsant to treat seizures.
f247d3ee-2366-550e-85e9-f62daee49eef	11719	case	4b606edf-07fc-4665-a7cd-a794004e5aca	Normal tissue origin incorrect	Notification	2012-10-31T00:00:00	Approved	Samples were created as tssDNA from Normal Tissue.  Actually are tssDNA extracted from Blood.  Should have been 10A instead of 11A.
678f8d9c-f56f-50c7-ac88-b1d12450e058	639	case	4ca9c0f2-1be9-4376-aa27-d9db948d3f68	Neoadjuvant therapy	Notification	2010-09-02T00:00:00	Approved	[intgen.org]: Subject Positive for Neo-Adjuvant Therapy
f1fd3cb6-094e-5502-80a0-47b5cc3a0ac3	5005	case	a795a841-9fd6-4eac-b871-a8c70248700f	Prior malignancy	Notification	2012-02-24T00:00:00	Approved	Prior malignancy with systemic treatment
e653931b-296b-5b45-9dc7-8564d042c4fe	5007	case	2c5fa2d4-8e35-42e4-8bca-9fb3371a19c8	Prior malignancy	Notification	2012-03-09T00:00:00	Approved	Prior Prostate malignancy as per pathology report.
0a4e3405-80c9-5794-8195-bea2617134f9	2922	case	883dc176-925a-44f7-9ec8-e0cce33c2a54	Neoadjuvant therapy	Notification	2011-06-28T00:00:00	Approved	Radiation treatment start date prior to date of procurement.
347d04d2-6be8-5a63-b8d5-a371632d622e	11906	case	69d0a566-5fbf-45f6-a240-649b06868e27	Qualified in error	Notification	2012-11-08T00:00:00	Approved	Subject qualified in error
64e055b1-fa05-55f4-a40c-2bfdd992857f	11912	case	a795a841-9fd6-4eac-b871-a8c70248700f	History of unacceptable prior treatment related to a prior/other malignancy	Notification	2012-11-10T00:00:00	Approved	Prior malignancy with systemic Treatment and locoregional radiation
5713c605-6238-5c78-9d74-1630d0ef9d85	1081	case	0d5e5a6b-5113-43f2-836c-776207b21b56	Subject withdrew consent	Redaction	2010-12-19T00:00:00	Approved	Subject_Withdrew_Consent_Date=12/16/2010
096d50f7-587a-5f69-8b3c-0fe67d8c555d	710	case	cc1459be-de8f-482e-9efe-65937db9dc45	Subject withdrew consent	Redaction	2010-09-02T00:00:00	Approved	[intgen.org]: Subject Withdrew Consent
e7026b1e-5b4a-5860-b6d0-fd0444583a00	11646	case	fb75eb9d-05be-4e6b-a515-f39efb15e66c	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
86030eb8-0a57-54b1-92b4-b8bce82ca7e5	5009	case	6c28f086-6a25-40b6-93eb-bba0014acda6	Prior malignancy	Notification	2012-03-09T00:00:00	Approved	Prior Prostate malignancy as per pathology report.
f0a9bf38-0433-5de9-b4d1-0a89ed6e799c	11914	case	91063e7e-60db-47a5-aeca-af7c37b1074e	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
5810b0e6-7b83-549f-9dc7-9750d8b68d25	11909	case	9734478b-05a2-4b5c-b8aa-9e6b0b0db02d	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.  Current TCGA tissue is reported as treated tissue.
d03651a9-98ed-5be7-8885-cb990452d228	643	case	d75996d6-9f02-4478-a4a1-dfa7ab41de77	Pathology outside specification	Notification	2010-09-02T00:00:00	Approved	[intgen.org]: Pathology Results off Spec
3103fdbd-983d-5ce6-8054-58fa1068347e	11659	case	658c8e31-2c60-40f0-ab25-d0d0168647db	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
bb6f5b0d-89ea-5aa1-be31-4af2c9fd9ead	11934	case	5438322c-9db0-4974-ba01-801020559f97	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.  Current TCGA tissue is reported as treated tissue.
a9329abb-f803-5c6c-816d-dac19de1975d	691	case	53abce1d-7e33-4ebd-832f-f3789f67377f	Normal class but appears diseased	Observation	2010-07-30T00:00:00	Approved	[schaefc]: Genomic data resembles tumor data
3a9b2ec6-d235-565c-9d88-284b5ed454ea	11918	case	2749c671-dee1-4d91-b3fa-4b50accf7a11	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
0b635743-4dd8-54d3-824a-89d8d7458f1f	11661	case	e948d951-9299-4dec-9772-60b4ac3569cb	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
bc5c5700-5249-5682-9a64-d0bbcaecb844	570	case	0164acd3-34db-4d35-b96c-936daad0ff22	Item in special subset	Notification	2010-07-30T00:00:00	Approved	[schaefc]: NECROSIS_STUDY
7e5af255-5a63-5b6a-bbff-58ad8b877751	11920	case	8e8688f7-bf69-432b-a5ac-4f5f4d5c10ba	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
c0ae8038-8eb5-5233-978c-85b56f3c0689	5006	case	7a4c0a14-ac97-4c2b-a9cc-68cb561b2494	Prior malignancy	Notification	2012-03-09T00:00:00	Approved	Prior Breast Cancer as per pathology report treatment not specified.
93d9d0fa-e589-50a0-9574-4f5c7a9bd79c	11921	case	827453a9-7388-4336-9ac5-4defcb904607	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
4191d541-e55a-5f74-aba5-a11a2f868438	11905	case	e1481049-c04e-48fe-8110-ac1d0ee86e75	Qualified in error	Notification	2012-11-08T00:00:00	Approved	Subject qualified in error
946316a2-342c-54a0-8b66-508ba5a6170c	11645	case	30a1fe5e-5b12-472c-aa86-c2db8167ab23	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
b9ad4785-a9ad-5a49-a69f-8060ea04179e	11917	case	a515cf2d-e918-4958-9bf6-e611b425a97e	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
6881340b-8b40-5611-808e-1f2376eb504c	709	case	a7b55dae-c9b8-45c6-986f-fb1055f1c67b	Subject withdrew consent	Redaction	2010-09-02T00:00:00	Approved	[intgen.org]: Subject Withdrew Consent
f316d2b9-a90f-5796-b2d1-b6b1bb411515	3384	case	9348e446-0e43-4210-b07e-c534980cbf62	Item in special subset	Notification	2011-09-18T00:00:00	Approved	Case came in as GBM.  BCR was notified that case was LGG.  Program Office determined this will be a Notification vs. a Redaction
b52340b3-b1c5-5ace-bea2-88cfe7f84723	2700	case	4c42dc4e-66b7-40bf-9fbe-b92543248198	Pathology outside specification	Notification	2011-05-15T00:00:00	Approved	[intgen.org]: Pathology Results off Spec
f5304469-29d8-57e9-b5e3-a8743eba61df	568	case	d0de6676-6ba1-4d79-a9b0-ec3f1e8a8775	Item in special subset	Notification	2010-07-30T00:00:00	Approved	[schaefc]: NECROSIS_STUDY
de83c215-4eb5-59da-b3b0-79a96f6f2259	11718	case	60e69f41-571e-4a1b-ae75-9d49eed620ca	Normal tissue origin incorrect	Notification	2012-10-31T00:00:00	Approved	Samples were created as tssDNA from Normal Tissue.  Actually are tssDNA extracted from Blood.  Should have been 10A instead of 11A.
4d6735c5-9746-5e54-b9d2-868aea030e2d	11657	case	372a4cc6-8fc9-4157-9cdc-fe020b176249	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
59214645-20b1-5f1d-a0db-6f90a114c470	566	case	2cb9975f-2d1e-4c74-867f-8b151c22b246	Item in special subset	Notification	2010-07-30T00:00:00	Approved	[schaefc]: NECROSIS_STUDY
7255d50a-17de-51f0-a466-d166f845dd30	826	case	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	Item may not meet study protocol	Observation	2010-10-28T00:00:00	Approved	Case identified (by Duke) as a secondary GBM; original annotation 06/22/09
d1636818-5251-58a2-8baa-3891780344c8	11658	case	b363b624-a5b0-46e4-b671-8813cc12eaf4	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
b34f2ab9-2db0-5957-826d-813046230188	638	case	d88b35a3-a291-457a-b15b-a314859b25c5	Neoadjuvant therapy	Notification	2010-09-02T00:00:00	Approved	[intgen.org]: Subject Positive for Neo-Adjuvant Therapy
fda9cd1e-4dca-5071-95a3-602ab1755b43	710	case	cc1459be-de8f-482e-9efe-65937db9dc45	Subject withdrew consent	Redaction	2010-09-02T00:00:00	Approved	Subject_Withdrew_Consent_Date=10/15/2009
b1bd40a8-b47b-58f1-823c-0d4da5e8eb4a	5008	case	3dddfc44-7bb1-4974-8a65-a84fd4bac484	Prior malignancy	Notification	2012-03-09T00:00:00	Approved	Prior Prostate malignancy as per pathology report treatment not specified.
de78c989-e74e-5ca3-a67a-66b02a9ccdf5	827	case	bb0aca6b-55ab-4b24-8e64-29e0c96a9862	Item may not meet study protocol	Observation	2010-10-28T00:00:00	Approved	Case identified (by Duke) as a secondary GBM; original annotation 06/22/09
95ac2a30-111f-52da-8edd-feee3ef6dd35	567	case	0ff91707-190e-4e2d-a3a0-42e3207225e9	Item in special subset	Notification	2010-07-30T00:00:00	Approved	[schaefc]: NECROSIS_STUDY
c6c58468-cdef-54c1-b893-ccdb58180e0e	11653	case	5da36fd2-0cea-41b8-90dc-b94c3c28cbd9	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
736f9851-1544-58aa-9700-e1d61f55ac6c	572	case	5f8f66a0-4068-4e9d-82fc-4fe1fc3f63aa	Item in special subset	Notification	2010-07-30T00:00:00	Approved	[schaefc]: NECROSIS_STUDY
8e661704-5605-513d-b99c-bf1e6926e6d6	828	case	29b34909-9cdc-4a52-b0ab-fa99f3ab17bb	Item may not meet study protocol	Observation	2010-10-28T00:00:00	Approved	Case identified (by Duke) as a secondary GBM; original annotation 06/22/09
2d8ab493-646e-561b-b595-862c4142f654	11650	case	7ef0564e-d95d-4df5-969b-b204c207daea	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
9fa76b4d-8c47-5379-b641-f68bf02cf2cf	11932	case	c29d73c0-c885-4105-bf74-38e9178e71c9	Case submitted is found to be a recurrence after submission	Notification	2012-11-10T00:00:00	Approved	Per enrollment form, patient had a prior diagnosis of a lower grade glioma.
e3e8eaca-1018-5c39-9526-1517975ed339	11656	case	f3e57166-c428-4a44-9396-679e3a2b16a2	Neoadjuvant therapy	Notification	2012-10-31T00:00:00	Approved	Per enrollment form, patient received neo-adjuvant therapy.
0a1fa52f-a502-532a-bded-44a068f30d5e	2907	case	d75996d6-9f02-4478-a4a1-dfa7ab41de77	Subject withdrew consent	Redaction	2011-06-17T00:00:00	Approved	[intgen.org]: Subject Withdrew Consent
4d65251b-efa6-56e2-808d-b7f5e9efcf05	3179	case	c2399f5d-dc29-42e9-81f1-1d164d4cc55d	Neoadjuvant therapy	Notification	2011-07-27T00:00:00	Approved	Subject positive for neoadjuvant therapy.
3471eb24-e05e-59eb-b2c8-bee7fb95224a	825	case	141a1ef1-9be6-46d1-b445-305b222727d2	Item may not meet study protocol	Observation	2010-10-28T00:00:00	Approved	Case identified (by Duke) as a secondary GBM; original annotation 06/22/09
845932b4-bbfd-522b-9fe4-1bc7e936d692	3175	case	c45e9e8b-35ab-4477-acdc-b18be0b3497d	Neoadjuvant therapy	Notification	2011-07-27T00:00:00	Approved	Subject positive for neoadjuvant therapy.
fe6585f4-e39d-53b8-a985-0707626cc4bc	571	case	c57d6674-08d1-4eda-9ec1-ae439923d7cf	Item in special subset	Notification	2010-07-30T00:00:00	Approved	[schaefc]: NECROSIS_STUDY
5b4bddef-0fe8-5312-8755-812da29066e5	709	case	a7b55dae-c9b8-45c6-986f-fb1055f1c67b	Subject withdrew consent	Redaction	2010-09-02T00:00:00	Approved	Subject_Withdrew_Consent_Date=1/12/2010